J Richard Lilly MD Shaaron R Towns MD and Associates PC

J Richard Lilly MD Shaaron R Towns MD and Associates PC was paid $8.59M by Medicaid between Jan 2018 and Dec 2024, across 102 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 52% of everything it billed.

33Billing provider infoJ RICHARD LILLY MD SHAARON R TOWNS MD AND ASSOCIATES PC
HYATTSVILLE, MD 20781

33aNPI1336135821assigned 09/21/2005

33bProvider typeGeneral Practice Physician

28Total paid$8.59M

24GClaims342,552

24DCodes billed102

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Practice Physician providers in Maryland

Rank by total paid#6 of 40

Median peer was paid$190K

This provider vs. median45×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	6,948	$138K
2019	7,365	$111K
2020	56,828	$1.53M
2021	66,367	$1.86M
2022	56,414	$1.73M
2023	72,049	$1.79M
2024incomplete	76,581	$1.43M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	52%	45,691	39,524	$4.49M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	13%	13,605	12,106	$1.10M
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	4.1%	3,037	2,885	$354K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	3.9%	2,622	2,504	$332K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	2.5%	1,882	1,790	$216K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	2.4%	1,992	1,888	$207K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	1.7%	2,698	2,468	$144K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	1.6%	1,344	1,262	$141K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.3%	4,932	4,607	$110K
92551		1.2%	11,453	10,801	$106K
80061	Lipid panel	1.1%	7,856	7,402	$94K
3008F		1.1%	44,123	37,110	$93K

90 more codes

93000		1.0%	6,172	$88K
36415	Collection of venous blood by venipuncture	<1%	26,543	$79K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	797	$76K
80053	Comprehensive metabolic panel	<1%	7,727	$70K
90686		<1%	2,902	$57K
84443	Thyroid stimulating hormone (TSH)	<1%	4,416	$56K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	7,546	$50K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,148	$50K
99051		<1%	7,612	$45K
3044F		<1%	6,715	$38K
86703		<1%	3,013	$38K
87899		<1%	3,047	$37K
3074F		<1%	14,449	$37K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	894	$35K
82570		<1%	5,650	$27K
D1206	Topical application of fluoride varnish	<1%	918	$23K
G8427	Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications	<1%	2,709	$23K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,685	$22K
3078F		<1%	10,729	$22K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	2,100	$21K
96160		<1%	8,182	$20K
90670		<1%	765	$16K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	298	$16K
99173		<1%	8,665	$15K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	3,094	$15K
90651		<1%	635	$14K
90677		<1%	161	$14K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,150	$13K
90698		<1%	591	$13K
99215	Doctor's office visit, returning patient (complex)	<1%	87	$12K
90734		<1%	518	$11K
99000		<1%	15,085	$11K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,282	$10K
81003		<1%	5,345	$10K
90633		<1%	431	$9K
G9225	Foot exam was not performed, reason not given	<1%	1,093	$8K
86592		<1%	2,029	$8K
S9452	Nutrition classes, non-physician provider, per session	<1%	3,428	$8K
3079F		<1%	3,216	$8K
90710		<1%	332	$7K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	133	$7K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	4,859	$6K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	256	$6K
G8417	Bmi is documented above normal parameters and a follow-up plan is documented	<1%	1,951	$5K
90744		<1%	223	$4K
90685		<1%	144	$3K
80050	General health panel	<1%	358	$3K
82948		<1%	724	$3K
86580		<1%	494	$3K
90680		<1%	127	$3K
99381		<1%	31	$3K
94760		<1%	1,736	$3K
84439		<1%	248	$2K
3075F		<1%	734	$2K
82043		<1%	391	$2K
G0008	Administration of influenza virus vaccine	<1%	212	$2K
87081		<1%	249	$1K
90715		<1%	81	$1K
84436		<1%	294	$1K
90696		<1%	72	$1K
99203	Doctor's office visit, new patient (routine)	<1%	13	$1K
G8420	Bmi is documented within normal parameters and no follow-up plan is required	<1%	595	$1K
82607		<1%	136	$1K
3077F		<1%	491	$1K
3017F		<1%	334	$956.23
90662		<1%	123	$833.51
3080F		<1%	424	$770.00
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	1,729	$642.80
2015F		<1%	74	$627.50
99188		<1%	370	$451.50
4551F		<1%	97	$412.00
98960		<1%	181	$410.91
87807		<1%	31	$370.77
81002		<1%	140	$277.63
G8399	Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed	<1%	797	$265.74
99443		<1%	55	$263.62
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	229	$132.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	<1%	558	$124.01
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	26	$110.00
1111F		<1%	292	$106.89
3046F		<1%	31	$106.00
81025		<1%	18	$95.76
4040F		<1%	199	$90.74
81015		<1%	317	$56.81
G8482	Influenza immunization administered or previously received	<1%	164	$41.14
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	0%	286	$0.00
36416		0%	15	$0.00
G0245	Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education	0%	12	$0.00
G8400	Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given	0%	92	$0.00
G0444	Annual depression screening, 5 to 15 minutes	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLILLY, J (OWNER)